Danaher Corporation (DHR) Fair Value 2026

DHR · Diagnostics & Research ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.1 /10

32 fundamental signals · 10 models active

Value Trap Risk

LOW (32/100)

Quick Summary — As of 2026-08-27, Danaher Corporation (DHR) trades at $215.68, versus a $126.02 median fair value across its 10 active models — 41.6% below the current price. QOC: 8.1/10. Value Trap Risk: 32/100 (LOW). 10/13 models active. Within that set, the Bayesian DCF component alone returns $140.32.

Key Facts

Ticker
DHR
Price
$215.68
Quality Score
8.1/10
Value Trap Risk
32/100
Models Active
10/13
Last Updated
Strength: Quality Score of 8.1/10 indicates strong fundamentals
Risk: Majority of models suggest overvaluation

Is Danaher Corporation (DHR) Undervalued or Overvalued in 2026?

According to CirclFi’s 10-model valuation engine, Danaher Corporation (DHR) appears overvalued as of : the median of 10 independent fair value estimates is $126.02, 41.6% below the current price of $215.68. Estimates range from $48.35 to $327.42. DHR scores 8.1/10 on fundamental quality and 32/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. DHR’s -41.6% gap is wider than that market norm, and the Diagnostics & Research sector median is -54.1%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Danaher Corporation Stock in 2026? →

What Fair Value Does Each Model Give DHR?

10 Intrinsic Value Models vs. Current Price ($215.68)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $140.32 -34.9%
Intrinsic · High Conviction
 $48.35 -77.6%
Ensemble · Low Conviction
 $111.72 -48.2%
Intrinsic · High Conviction
 $59.49 -72.4%
Unlock the Full Matrix

Access 6 additional models including Markov DDM, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is DHR's Fair Value Range?

Spread across 10 independent models · $48.35 to $327.42

CirclFi's 10 active models place Danaher Corporation (DHR) between $48.35 and $327.42 per share, a spread of 221% of the median. The median of that range — $126.02 — is the fair value CirclFi publishes for DHR, against a current price of $215.68.

Low · EPVHigh · Regime Cross
$48.35median $126.02$327.42
Where the range comes from
Most bearish modelEarnings Power Value (EPV)$48.35
Most bullish modelRegime Cross-Sectional$327.42
Model agreement1 bullish · 9 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for DHR. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on DHR, not a CirclFi price target. How each model works →

What Is Danaher Corporation (DHR) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Danaher Corporation's intrinsic value is estimated at $126.02. Trading at its current price of $215.68, the valuation engine raises significant caution: 9 of 10 models flag downside risk, projecting a median implied return of -41.6%. The most optimistic model, Regime Cross, places fair value at $327.42 (+51.8%), while EPV — the most conservative — estimates $48.35 (-77.6%). This +129.4% gap reflects genuine analytical uncertainty about Danaher Corporation's intrinsic worth. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About DHR?

10 of 13 models are currently active for DHR. Of these, 1 model suggests upside while 9 models suggest overvaluation. Taken together, their median fair value for DHR is $126.02 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $140.32 on its own, implying -34.9% downside from the current price. See which stocks rank higher →

How Does DHR Rank in Diagnostics & Research?

Among 52 Diagnostics & Research stocks, DHR ranks #9 by Quality of Company score. CirclFi's QOC score of 8.1/10 evaluates 32 fundamental signals. A score of 8.1 places DHR in the top tier.

Danaher Corporation's positioning within the Diagnostics & Research segment means that revenue per drug plays an outsized role in fundamental analysis. The sector's unique characteristics — including licensing and M&A optionality — shape both the opportunity set and risk profile.

Is DHR a Value Trap?

CirclFi's Value Trap algorithm assigns DHR a score of 32/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for Danaher Corporation. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Danaher Corporation scores 8.1 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +129.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every DHR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across DHR's 10 active models, average confidence is 53%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Danaher Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Diagnostics & Research Stocks Should You Also Analyze?

11 related Diagnostics & Research stocks with 13-model coverage

IDXGInterpace Biosciences, Inc.QOC 8.2SHCSotera Health CompanyQOC 8.1IQVIQVIA Holdings Inc.QOC 8.3DGXQuest Diagnostics IncorporatedQOC 7.9MTDMettler-Toledo International Inc.QOC 8.7TMOThermo Fisher Scientific Inc.QOC 7.8ADPTAdaptive Biotechnologies CorporationQOC 7.2BDSXBiodesix, Inc.QOC 6.3FUNIHypha Labs, Inc.QOC 3.9IDXXIDEXX Laboratories, Inc.QOC 9.5MEDPMedpace Holdings, Inc.QOC 9.3

Read investment analysis: IDXG · SHC · IQV · DGX · MTD · TMO · ADPT · BDSX · FUNI · IDXX · MEDP

Which Other Stocks Have a Similar Quality Score to DHR?

7 companies across all industries closest to DHR’s Quality of Company score of 8.1/10.

CBCCentral Bancompany, Inc.QOC 8.1PLPCPreformed Line Products CompanyQOC 8.1PBAPembina Pipeline CorporationQOC 8.1ZBRAZebra Technologies CorporationQOC 8.1SEBSeaboard CorporationQOC 8.1BOWBowhead Specialty Holdings Inc.QOC 8.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: CBC · PLPC · PBA · ZBRA · SEB · BOW · NVDA

What Else Do Investors Ask About Danaher Corporation’s Valuation?

What is Danaher Corporation's intrinsic value in 2026?

CirclFi puts Danaher Corporation (DHR)'s intrinsic value at $126.02 — the median of 10 independent model estimates as of 2026-08-27, ranging from $48.35 to $327.42. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $140.32 on its own. The Quality of Company score is 8.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is DHR overvalued or undervalued right now?

At $215.68, 1 of 10 active models suggest DHR may be undervalued, while 9 indicate potential overvaluation. The median of all 10 fair value estimates is $126.02, 41.6% below the current price of $215.68 — a consensus view that DHR is overvalued. The assessment depends on which methodology best fits Danaher Corporation's business model in Diagnostics & Research.

What does a Quality of Company score of 8.1 mean for DHR?

Danaher Corporation's QOC of 8.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on DHR?

CirclFi analyzes DHR with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on DHR?

Of the 10 models currently active on DHR, Regime Cross-Sectional is the most bullish at $327.42 per share, and Earnings Power Value (EPV) is the most bearish at $48.35. CirclFi's published fair value for DHR is the median of that range, $126.02, not either extreme. The gap between the two ends equals 221% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is DHR a value trap in 2026?

Danaher Corporation's Value Trap score is 32/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 10-model valuation engine, Danaher Corporation (DHR) has a median fair value of $126.02 — 41.6% below the current price of $215.68 — as of 2026-08-27.” Source: circlfi.com/stock/DHR/ · Methodology
Primary sources for this DHR valuation
  • Financial statements: Danaher Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0000313616) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for DHR as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on DHR.

Unlock All 10 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

6 models hidden for DHR Unlock All 10 — $39/mo